blog

DPharm 2018: A world where health records are no longer isolated.

By BBK Worldwide on Thu, Oct 18, 2018 | 1 min read

Pharma15 Live! sat down with David Levesque to discuss the goal and mission of Andaman7. Throughout the DPharm, one of the main topics was about new ways to allow patients to access their own data.

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital

DPharm 2018: The Demands of DPharm Idol

By BBK Worldwide on Thu, Oct 11, 2018 | 1 min read

Pharma15 Live! sat down Valerie Bowling, drug development industry researcher and founder of DPharm, during the conference to discuss this year’s presentations, and the very popular DPharm Idol competition:

Topics: Pharma15, clinical research, clinical trials, patient data, Disruptive Innovation, Conferences

DPharm 2018: Who Owns Patient Data, and Who’s Just Visiting?

By BBK Worldwide on Wed, Oct 10, 2018 | 1 min read

What does patient data ownership actually mean? According to Craig Lipset, head of clinical innovation at Pfizer and DPharm 2018 co-chair, that is still an open question. Pharma15 Live! chatted with him about it at the DPharm 2018 conference.

Topics: Pharma15, Patient Experience, clinical research, clinical trials, patient data, Disruptive Innovation, Conferences

When it Comes to Patient Data, Think First About the Patient

By BBK Worldwide on Thu, Aug 9, 2018 | 1 min read

 

Experts across the healthcare industry agree that patients should be able to easily access their medical data. While this sentiment is shared among key industry stakeholders, the ideas of “consumer centricity”, and how researchers specifically stand to benefit from delivering patient data, are popular talking points among experts in our industry.

Topics: patient data, clinical research, clinical trials, Pharma15

Agree or Disagree: Smaller Pharma Companies Are Leading the Way in Digital Health

By BBK Worldwide on Tue, Jul 24, 2018 | 1 min read

For digital health to be more widely implemented across the healthcare industry, smaller biopharma companies must be the first to demonstrate its efficacy. In this way, they must deliver specific real-world cases to prove to bigger pharma companies that digital health solutions are viable for the clinical R&D industry.

Topics: digital health, mHealth, clinical research, clinical trials

Taming the Study Data Explosion at DIA 2018

By BBK Worldwide on Wed, Jun 27, 2018 | 2 min read

While it’s hard to believe that today is the last day on the DIA 2018 exhibition floor, we are excited to continue collaborating, presenting, and interacting with our industry colleagues. Our poster session “Real World Data Meets Real World Evidence in Patient Recruitment and Engagement” made way for productive conversation that embodies the spirit of the DIA Annual Meeting. Today, we are back with a new poster session titled “Taming the Study Data Explosion: How to Leverage KPIs to Maximize Performance.”

Topics: DIA 2018, KPIs, clinical research, clinical trials

Clinical Trial Advertisers: Take Note of These Digital Trends

By BBK Worldwide on Tue, Jun 5, 2018 | 3 min read

The way people consume media is changing. With a projected 237.6 million estimated smartphone users by the end of 2018 in the United States alone (an increase of 13.3 million users from last year), the way people are accessing information is increasingly going mobile. Additionally, the Pew Research Center suggests that 64 percent of Americans between the ages 50 to 64 are using social media, preferring mediums like Facebook and YouTube. While the clinical trial industry is known to be slow in adopting newer technologies, the implications of these observed trends for patient recruitment speak for themselves. To get a closer look at the impact of digital media on clinical trial advertising, we spoke with our Director of Media and Research Sarah Mandracchia for her insights on some of the tactics and strategies that are shaping direct-to-consumer outreach in 2018.

Topics: Digital Platforms, clinical trials, clinical research, advertising

Watch On Demand: Experts Square Off on Clinical Trial Advertising

By BBK Worldwide on Fri, Mar 30, 2018 | 1 min read

Screen Shot 2018-03-30 at 3.45.36 PMJust last week, industry experts Matt Kibby, Shwen Gwee, and Dan Sfera squared off on a live 15-minute showdown, debating the timely topic of direct-to-consumer advertising to support clinical trial recruitment.

Moderated by Kaitlin Kelleher, conference producer at Cambridge Healthtech Institute, our challengers were tasked with debating many of the burning issues surrounding clinical trial advertising in today's shifting patient recruitment landscape.

We're excited to present the full debate for your viewing pleasure. And for those who were unable to catch the event live, we hope you enjoy it!

Topics: clinical trials, advertising, global patient recruitment, Pharma15

The Debate is Heating Up!

By Aaron Fleishman on Wed, Mar 21, 2018 | 2 min read

When it comes to clinical trial advertising, is “the juice worth the squeeze,” so to speak? To get at the heart of this issue, BBK Worldwide is bringing together industry experts to square off on the live video stream debate “Does Clinical Trial Advertising Deliver?” 

Join us on March 28th at 1:00pm EDT for a live 15-minute showdown between experts, debating the timely topic of direct-to-consumer advertising to support clinical trial recruitment.

With this lineup, you will not want to miss it!

Topics: global patient recruitment, clinical trials, Patient Recruitment, Pharma15

Insights from Dr. Elliot Rosenstein: Referring Physicians in Clinical Trials

By BBK Worldwide on Wed, Jan 31, 2018 | 4 min read

 

For our latest eBook 21st Century Research Champions, we reached out to physicians to gain a deeper understanding about their attitudes and actions with regard to clinical research, and explored tested strategies in building relationships with physicians to enhance patient recuritment. As it turns out, physicians were more than happy to provide their insights into the value of referring physician programs and to elaborate on their willingness to contribute to clinical research. We interviwed Dr. Eliott Rosenstein -- a physician with more than 40 years of experience and Director of the Institute for Rheumatic and Autoimmune diseases -- to get his take on our latest eBook and the importance of referring physicians in clinical trial patient recruitment.

Topics: Physician Referrals, clinical research, clinical trials, Most Viewed

 
Subscribe To Our Blog